Recent trends in ANDA litigation
Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
BMS illegally promoted schizophrenia drug, says attorney general
Pfizer hiked price by 2600%, says competition watchdog.
Court ruling paves way for decision on PrEP.
Generics firms free to exploit gap in Pfizer’s patent defences.
But US financial regulator launches own probe.
Company will now focus solely on its miniLab technology.
Actions of Chinese subsidiaries violated US bribery laws, says SEC.
EU court to rule on legal row.